{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:27:17Z","timestamp":1759332437586},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T00:00:00Z","timestamp":1316131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s10147-011-0316-1","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T08:05:09Z","timestamp":1316073909000},"page":"462-469","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection"],"prefix":"10.1007","volume":"17","author":[{"given":"Yusuke","family":"Okuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuru","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ajisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,16]]},"reference":[{"key":"316_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","volume":"23","author":"N Crum-Cianflone","year":"2009","unstructured":"Crum-Cianflone N, Hullsiek KH, Marconi V et al (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 23:41\u201350","journal-title":"AIDS"},{"key":"316_CR2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2005.03.4413","volume":"24","author":"EA Engels","year":"2006","unstructured":"Engels EA, Brock MV, Chen J et al (2006) Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 24:1383\u20131388","journal-title":"J Clin Oncol"},{"key":"316_CR3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","volume":"20","author":"EA Engels","year":"2006","unstructured":"Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980\u20132002. AIDS 20:1645\u20131654","journal-title":"AIDS"},{"key":"316_CR4","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2003.01.096","volume":"21","author":"M Herida","year":"2003","unstructured":"Herida M, Mary-Krause M, Kaphan R et al (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21:3447\u20133453","journal-title":"J Clin Oncol"},{"key":"316_CR5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1378\/chest.102.6.1704","volume":"102","author":"KS Sridhar","year":"1992","unstructured":"Sridhar KS, Flores MR, Raub WA Jr et al (1992) Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 102:1704\u20131708","journal-title":"Chest"},{"key":"316_CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D","volume":"88","author":"U Tirelli","year":"2000","unstructured":"Tirelli U, Spina M, Sandri S et al (2000) Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 88:563\u2013569","journal-title":"Cancer"},{"key":"316_CR7","doi-asserted-by":"crossref","unstructured":"Vyzula R, Remick SC (1996) Lung cancer in patients with HIV infection. Lung Cancer 15:325\u2013339","DOI":"10.1016\/0169-5002(95)00596-X"},{"key":"316_CR8","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","volume":"27","author":"CG Azzoli","year":"2009","unstructured":"Azzoli CG, Baker S Jr, Temin S et al (2009) American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27:6251\u20136266","journal-title":"J Clin Oncol"},{"key":"316_CR9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","volume":"311","author":"Non-small Cell Lung Cancer Collaborative Group","year":"1995","unstructured":"Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 311:899\u2013909","journal-title":"BMJ"},{"key":"316_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/518606","volume":"45","author":"GD Kirk","year":"2007","unstructured":"Kirk GD, Merlo C, O\u2019Driscoll P et al (2007) HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 45:103\u2013110","journal-title":"Clin Infect Dis"},{"key":"316_CR11","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2004.99.265","volume":"22","author":"T Powles","year":"2004","unstructured":"Powles T, Bower M (2004) HIV and the risk of lung cancer. J Clin Oncol 22:1348\u20131349 (author reply 1349\u20131350)","journal-title":"J Clin Oncol"},{"key":"316_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1758-2652-13-51","volume":"13","author":"K Petoumenos","year":"2010","unstructured":"Petoumenos K, Hui E, Kumarasamy N et al (2010) Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc 13:51","journal-title":"J Int AIDS Soc"},{"key":"316_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.lungcan.2008.11.018","volume":"65","author":"A Lavole","year":"2009","unstructured":"Lavole A, Chouaid C, Baudrin L et al (2009) Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer 65:345\u2013350","journal-title":"Lung Cancer"},{"key":"316_CR14","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","volume":"285","author":"M Frisch","year":"2001","unstructured":"Frisch M, Biggar RJ, Engels EA et al (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736\u20131745","journal-title":"JAMA"},{"issue":"18\u201320","key":"316_CR15","first-page":"26","volume":"18","author":"SK Cinti","year":"2008","unstructured":"Cinti SK, Gandhi T, Riddell J 4th (2008) Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier? AIDS Read 18(18\u201320):26\u201332","journal-title":"AIDS Read"},{"key":"316_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO et al (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59\u201367","journal-title":"Lancet"},{"key":"316_CR17","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jama.279.19.1554","volume":"279","author":"II Wistuba","year":"1998","unstructured":"Wistuba II, Behrens C, Milchgrub S et al (1998) Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA 279:1554\u20131559","journal-title":"JAMA"},{"key":"316_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00002030-200302140-00011","volume":"17","author":"M Bower","year":"2003","unstructured":"Bower M, Powles T, Nelson M et al (2003) HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17:371\u2013375","journal-title":"AIDS"},{"key":"316_CR19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/ajrccm\/137.5.1110","volume":"137","author":"JM Samet","year":"1988","unstructured":"Samet JM, Wiggins CL, Humble CG et al (1988) Cigarette smoking and lung cancer in New Mexico. Am Rev Respir Dis 137:1110\u20131113","journal-title":"Am Rev Respir Dis"},{"key":"316_CR20","doi-asserted-by":"crossref","unstructured":"The National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. doi: 10.1056\/NEJMoa1102873","DOI":"10.1056\/NEJMoa1102873"},{"key":"316_CR21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2214\/ajr.164.3.7863877","volume":"164","author":"CS White","year":"1995","unstructured":"White CS, Haramati LB, Elder KH et al (1995) Carcinoma of the lung in HIV-positive patients: findings on chest radiographs and CT scans. AJR Am J Roentgenol 164:593\u2013597","journal-title":"AJR Am J Roentgenol"},{"key":"316_CR22","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/01.aids.0000226949.64600.f9","volume":"20","author":"JR Grubb","year":"2006","unstructured":"Grubb JR, Moorman AC, Baker RK et al (2006) The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 20:1095\u20131107","journal-title":"AIDS"},{"key":"316_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.qai.0000232260.95288.93","volume":"43","author":"MV Brock","year":"2006","unstructured":"Brock MV, Hooker CM, Engels EA et al (2006) Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 43:47\u201355","journal-title":"J Acquir Immune Defic Syndr"},{"key":"316_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/QAD.0b013e3280118fca","volume":"21","author":"AK Chaturvedi","year":"2007","unstructured":"Chaturvedi AK, Pfeiffer RM, Chang L et al (2007) Elevated risk of lung cancer among people with AIDS. AIDS 21:207\u2013213","journal-title":"AIDS"},{"key":"316_CR25","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/JTO.0b013e3181f387fd","volume":"5","author":"S Pakkala","year":"2010","unstructured":"Pakkala S, Ramalingam SS (2010) Lung cancer in HIV-positive patients. J Thorac Oncol 5:1864\u20131871","journal-title":"J Thorac Oncol"},{"key":"316_CR26","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2009.25.6149","volume":"28","author":"AM Levine","year":"2010","unstructured":"Levine AM, Seaberg EC, Hessol NA et al (2010) HIV as a risk factor for lung cancer in women: data from the Women\u2019s Interagency HIV Study. J Clin Oncol 28:1514\u20131519","journal-title":"J Clin Oncol"},{"key":"316_CR27","doi-asserted-by":"crossref","unstructured":"Pakkala S, Chen Z, Rimland D et al (2011) Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer. doi: 10.1002\/cncr.26242","DOI":"10.1002\/cncr.26242"},{"key":"316_CR28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thx.2005.052373","volume":"61","author":"J Cadranel","year":"2006","unstructured":"Cadranel J, Garfield D, Lavole A et al (2006) Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 61:1000\u20131008","journal-title":"Thorax"},{"key":"316_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0761-8417(07)90121-2","volume":"63","author":"A Lavole","year":"2007","unstructured":"Lavole A, Epaud C, Rosencher L et al (2007) Lung cancer in HIV-positive patients. Rev Pneumol Clin 63:167\u2013175","journal-title":"Rev Pneumol Clin"},{"key":"316_CR30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","volume":"65","author":"SE Cotter","year":"2006","unstructured":"Cotter SE, Grigsby PW, Siegel BA et al (2006) FDG-PET\/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65:720\u2013725","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"316_CR31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.1988.6.5.863","volume":"6","author":"LY Chak","year":"1988","unstructured":"Chak LY, Gill PS, Levine AM et al (1988) Radiation therapy for acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma. J Clin Oncol 6:863\u2013867","journal-title":"J Clin Oncol"},{"key":"316_CR32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1984.03350070052024","volume":"252","author":"JS Cooper","year":"1984","unstructured":"Cooper JS, Fried PR, Laubenstein LJ (1984) Initial observations of the effect of radiotherapy on epidemic Kaposi\u2019s sarcoma. JAMA 252:934\u2013935","journal-title":"JAMA"},{"key":"316_CR33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/JTO.0b013e3181d3ccf2","volume":"5","author":"A Makinson","year":"2010","unstructured":"Makinson A, Pujol JL, Le Moing V et al (2010) Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer. J Thorac Oncol 5:562\u2013571","journal-title":"J Thorac Oncol"},{"key":"316_CR34","unstructured":"Rowinsky E, Donehower R (1997) Pharmacology of cancer chemotherapy\u2014antimicrotubule agents. In: De Vita VT, Hellman S, Rosember SA (eds) Cancer principles and practice of oncology, 5th edn. Lippincott\u2013Raven, Philadelphia, pp 467\u2013483"},{"key":"316_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/QAI.0b013e31818ceaa4","volume":"50","author":"JA Aberg","year":"2009","unstructured":"Aberg JA (2009) Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr 50:54\u201364","journal-title":"J Acquir Immune Defic Syndr"},{"key":"316_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/QAD.0b013e32831c8adc","volume":"23","author":"J Huang","year":"2009","unstructured":"Huang J, Meixner L, Fernandez S et al (2009) A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS 23:51\u201357","journal-title":"AIDS"},{"key":"316_CR37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1210\/jc.2006-2216","volume":"92","author":"MJ Bolland","year":"2007","unstructured":"Bolland MJ, Grey AB, Horne AM et al (2007) Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. J Clin Endocrinol Metab 92:1283\u20131288","journal-title":"J Clin Endocrinol Metab"},{"key":"316_CR38","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0b013e3282ed6338","volume":"21","author":"MJ Silverberg","year":"2007","unstructured":"Silverberg MJ, Neuhaus J, Bower M et al (2007) Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 21:1957\u20131963","journal-title":"AIDS"},{"key":"316_CR39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1995.tb05796.x","volume":"40","author":"KT Kivisto","year":"1995","unstructured":"Kivisto KT, Kroemer HK, Eichelbaum M (1995) The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40:523\u2013530","journal-title":"Br J Clin Pharmacol"},{"key":"316_CR40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1378\/chest.103.2.410","volume":"103","author":"J Karp","year":"1993","unstructured":"Karp J, Profeta G, Marantz PR et al (1993) Lung cancer in patients with immunodeficiency syndrome. Chest 103:410\u2013413","journal-title":"Chest"},{"key":"316_CR41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3816\/CLC.2010.n.051","volume":"11","author":"GA D\u2019Jaen","year":"2010","unstructured":"D\u2019Jaen GA, Pantanowitz L, Bower M et al (2010) Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer 11:396\u2013404","journal-title":"Clin Lung Cancer"},{"key":"316_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/MO:21:2:109","volume":"21","author":"JP Spano","year":"2004","unstructured":"Spano JP, Massiani MA, Bentata M et al (2004) Lung cancer in patients with HIV Infection and review of the literature. Med Oncol 21:109\u2013115","journal-title":"Med Oncol"},{"key":"316_CR43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.JTO.0000263707.31202.d7","volume":"2","author":"R Hakimian","year":"2007","unstructured":"Hakimian R, Fang H, Thomas L et al (2007) Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2:268\u2013272","journal-title":"J Thorac Oncol"},{"key":"316_CR44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-5002(00)00129-X","volume":"29","author":"F Massera","year":"2000","unstructured":"Massera F, Rocco G, Rossi G et al (2000) Pulmonary resection for lung cancer in HIV-positive patients with low (<200 lymphocytes\/mm(3)) CD4(+) count. Lung Cancer 29:147\u2013149","journal-title":"Lung Cancer"},{"key":"316_CR45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/JTO.0b013e3181b27b15","volume":"4","author":"SH Ou","year":"2009","unstructured":"Ou SH, Ziogas A, Zell JA (2009) Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol 4:1083\u20131093","journal-title":"J Thorac Oncol"},{"key":"316_CR46","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","volume":"362","author":"M Maemondo","year":"2010","unstructured":"Maemondo M, Inoue A, Kobayashi K et al (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380\u20132388","journal-title":"N Engl J Med"},{"key":"316_CR47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","volume":"11","author":"T Mitsudomi","year":"2009","unstructured":"Mitsudomi T, Morita S, Yatabe Y et al (2009) Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 11:121\u2013128","journal-title":"Lancet Oncol"},{"key":"316_CR48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","volume":"361","author":"R Rosell","year":"2009","unstructured":"Rosell R, Moran T, Queralt C et al (2009) Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 361:958\u2013967","journal-title":"N Engl J Med"},{"key":"316_CR49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/S12094-010-0473-0","volume":"12","author":"R Rosell","year":"2009","unstructured":"Rosell R, Moran T, Carcereny E et al (2009) Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain. Clin Transl Oncol 12:75\u201380","journal-title":"Clin Transl Oncol"},{"key":"316_CR50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-200544020-00001","volume":"44","author":"T Antoniou","year":"2005","unstructured":"Antoniou T, Tseng AL (2005) Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet 44:111\u2013145","journal-title":"Clin Pharmacokinet"},{"key":"316_CR51","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/bjs.1800840808","volume":"84","author":"MT Alshafie","year":"1997","unstructured":"Alshafie MT, Donaldson B, Oluwole SF (1997) Human immunodeficiency virus and lung cancer. Br J Surg 84:1068\u20131071","journal-title":"Br J Surg"},{"key":"316_CR52","first-page":"903","volume":"6","author":"L Bertolaccini","year":"2008","unstructured":"Bertolaccini L, Lyb\u00e9ris P, Soncini S et al (2008) Clinical characteristic lung cancer in HIV-infected patients. Cancer Therapy 6:903\u2013906","journal-title":"Cancer Therapy"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0316-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-011-0316-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0316-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:37:25Z","timestamp":1559126245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-011-0316-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,16]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s10147-011-0316-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,16]]}}}